Independent news has never been so important.

Did you know that you can get Democracy Now! delivered to your inbox every day? Sign up for our Daily News Digest today! Don't worry, we'll never share or sell your information.

Emergent BioSolutions Reaped Millions in Federal Contracts But Has Yet to Deliver Any COVID Vaccines

HeadlineMay 20, 2021

Executives from biotech company Emergent BioSolutions were grilled by lawmakers Wednesday over multiple failures in their manufacturing of coronavirus vaccines, which led the company to throw out 15 million doses earlier this year due to contamination. This is New York Congressmember Carolyn Maloney speaking at the hearing Wednesday.

Rep. Carolyn Maloney: “This is unfair to the American taxpayer, to say the very least. When you have a contract, you should produce the product. So far, we haven’t even gotten one dose of the product out to the American taxpayer, yet you have been able to get bonuses, millions of dollars in pay going out to executives, and they have not completed the contract.”

Former government officials serve on the board of Emergent, and the company spends an average of $3 million a year on lobbying lawmakers.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation